The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli

Biomaterials

Volumn 33, Issue 7, 2012, Pages 2327-2333

  Cui, Yan ^a,b   Zhao, Yuyun ^b   Tian, Yue ^b   Zhang, Wei ^b   Lü, Xiaoying ^a   Jiang, Xingyu ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

Gold nanoparticle; Molecular mechanism; ROS; Transcriptomic proteomic analysis

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL AGENT; ATP LEVEL; ATP-ASE ACTIVITY; CELLULAR DEATH; GOLD NANOPARTICLES; GOLD NPS; GRAM-NEGATIVE BACTERIA; MEMBRANE POTENTIALS; MOLECULAR MECHANISM; PROTEOMIC APPROACHES; REACTIVE OXYGEN SPECIES; ROS; TRANSCRIPTOMIC/PROTEOMIC ANALYSIS;

BACTERIA; BACTERICIDES; BIOCHEMISTRY; ESCHERICHIA COLI; NANOPARTICLES;

GOLD;

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; BACTERIAL ENZYME; BACTERICIDE; GOLD NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TRANSFER RNA;

ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CHEMOTAXIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ESCHERICHIA COLI; MEMBRANE DAMAGE; MEMBRANE POTENTIAL; MICROARRAY ANALYSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RIBOSOME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; GOLD; HYDROGEN PEROXIDE; MATERIALS TESTING; METAL NANOPARTICLES; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; OXIDANTS; REACTIVE OXYGEN SPECIES;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 84855750835     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.057     Document Type: Article

References (56)

1. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325(5944):1089-1093.
2. Yacoby I., Benhar I. Antibacterial nanomedicine. Nanomedicine 2008, 3(3):329-341.
3. Rao J.H. Shedding light on tumors using nanoparticles. ACS Nano 2008, 2(10):1984-1986.
4. Amstad E., Textor M., Reimhult E. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale 2011, 3(7):2819-2843.
5. Bandyopadhyay D., Prashar D., Luk Y.Y. Anti-fouling chemistry of chiral mono layers: enhancing biofilm resistance on racemic surface. Langmuir 2011, 27(10):6124-6131.
6. Li Q., Mahendra S., Lyon D.Y., Brunet L., Liga M.V., Li D., et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res 2008, 42(18):4591-4602.
7. Hu W.B., Peng C., Luo W.J., Lv M., Li X.M., Li D., et al. Graphene-based antibacterial paper. ACS Nano 2010, 4(7):4317-4323.
8. Banerjee I., Mondal D., Martin J., Kane R.S. Photoactivated antimicrobial activity of carbon nanotube-porphyrin conjugates. Langmuir 2010, 26(22):17369-17374.
9. Chaloupka K., Malam Y., Seifalian A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 2010, 28(11):580-588.
10. Huang Z., Zheng X., Yan D., Yin G., Liao X., Kang Y., et al. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 2008, 24(8):4140-4144.
11. Jones N., Ray B., Ranjit K.T., Manna A.C. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 2008, 279:71-76.
12. Kang S., Herzberg M., Rodrigues D.F., Elimelech M. Antibacterial effects of carbon nanotubes: size does matter!. Langmuir 2008, 24(13):6409-6413.
13. Lyon D.Y., Brunet L., Hinkal G.W., Wiesner M.R., Alvarez P.J.J. Antibacterial activity of fullerene water suspensions (nC60) is not due to ROS-mediated damage. Nano Lett 2008, 8(5):1539-1543.
14. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38(6):1759-1782.
15. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticles for biology and medicine. Angew Chem Int Ed 2010, 49(19):3280-3294.
16. Jin R. Super robust nanoparticles for biology and biomedicine. Angew Chem Int Ed 2008, 47(36):6750-6753.
17. Salata O. Applications of nanoparticles in biology and medicine. JNanobiotechnology 2004, 2(1):3.
18. Thanh N.T.K., Green L.A.W. Functionalisation of nanoparticles for biomedical applications. Nano Today 2010, 5(13):213-230.
19. Gu H., Ho P.L., Tong E., Wang L., Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 2003, 3(9):1261-1263.
20. Zhao Y., Tian Y., Cui Y., Liu W., Ma W., Jiang X. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. JAmer Chem Soc 2010, 132(35):12349-12356.
21. Ma W., Cui Y., Zhao Y., Zheng W., Zhang W., Jiang X., et al. Progress of antibacterial mechanisms study on nanoparticles. Acta Biophys Sinica 2010, 26(8):638-648.
22. Freiberg C., Bröz Oesterhelt H., Labischinski H. The impact of transcriptome and proteome analyses on antibiotic drug discovery. Curr Opin Microbiol 2004, 7(5):451-459.
23. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. Acommon mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130(5):797-810.
24. Miesel L., Greene J., Black T.A. Genetic strategies for antibacterial drug discovery. Nat Rev Genet 2003, 4(6):442-456.
25. Lü X., Lu H., Zhao L., Yang Y., Lu Z. Genome-wide pathways analysis of nickel ion-induced differential genes expression in fibroblasts. Biomaterials 2010, 31(8):1965-1973.
26. Lü X., Bao X., Huang Y., Qu Y., Lu H., Lu Z. Mechanisms of cytotoxicity of nickel ions based on gene expression profiles. Biomaterials 2009, 30(2):141-148.
27. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. JProteome Res 2006, 5(4):916-924.
28. Li W.R., Xie X.B., Shi Q.S., Duan S.S., Ouyang Y.S., Chen Y.B. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. BioMetals 2011, 24(1):135-141.
29. Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26-A 1999, National committee for clinical laboratory standards, NCCLS, Wayne, PA, USA.
30. Arnt L., Rennie J.R., Linser S., Willumeit R., Tew G.N. Membrane activity of biomimetic facially amphiphilic antibiotics. JPhys Chem B 2006, 110(8):3527-3532.
31. Seaver L.C., Imlay J.A. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. JBacteriol 2001, 183(24):7173-7181.
32. Levison M.E. Pharmacodynamics of antimicrobial drugs. Infect Dis Clin North Am 2004, 18(3):451-465.
33. Pankey G.A., Sabath L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections. Clin Infect Dis 2004, 38(6):864-870.
34. Zheng Q., Wang X.J. GOEAST: a web-based software toolkit for gene ontology enrichment analysis. Nucleic Acids Res 2008, 36:W358-W363.
35. Kaim G., Dimroth P. ATP synthesis by F-type ATP synthase is obligatorily dependent on the transmembrane voltage. EMBO J 1999, 18(50):4118-4127.
36. Dimroth P., Kaim G., Matthey U. Crucial role of the membrane potential for ATP synthesis by F1F0 ATP syntheases. JExp Biol 2000, (203):51-59.
37. Su H.L., Chou C.C., Hung D.J., Lin S.H., Pao I.C., Lin J.H., et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30(30):5979-5987.
38. Su H.L., Lin S.H., Wei J.C., Pao I.C., Chiao S.H., Huang C.C., et al. Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria. PLoS One 2011, 6(6):e21125.
39. Carbon J., David H., Studier M.H. Thiobases in Escherichia coli transfer RNA-2- thiocytosine and 5-methylaminomethyl-2-thiouracil. Science 1968, 161(3846):1146.
40. Sayed H.H., Shamroukh A.H., Rashad A.E. Synthesis and biological evaluation of some pyrimidine, pyrimido [2,1-b] [1,3] thiazine and thiazolo [3,2-a] pyrimidine derivatives. Acta Pharm 2006, 56(2):231-244.
41. Pedersen P. Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease. JBioenerg Biomembr 2007, 39(5):349-355.
42. Zharova T.V., Vinogradov A.D. Energy-dependent transformation of F0F1-ATPase in paracoccus denitrificans plasma membranes. JBiol Chem 2004, 279(13):12319-12324.
43. Arechaga I., Jones P.C. The rotor in the membrane of the ATP synthase and relatives. FEBS Lett 2001, 494(1-2):1-5.
44. Shaw K.J., Miller N., Liu X.J., Lerner D., Wan J., Bittner A., et al. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. JMol Microbiol Biotechnol 2003, 5(2):105-122.
45. Asad N.R., Asad L.M.B.O., Almeida CEBd, Felzenszwalb I., Cabral-Neto J.B., Leitao A.C. Several pathways of hydrogen peroxide action that damage the E.coli genome. Genet Mol Biol 2004, 27:291-303.
46. Storz G., Jacobson F.S., Tartaglia L.A., Morgan R.W., Silveira L.A., Ames B.N. An alkyl hydroperoxide reductase induced by oxidative stress in Salmonella typhimurium and Escherichia coli: genetic characterization and cloning of Ahp. JBacteriol 1989, 171(4):2049-2055.
47. Gou N., Onnis Hayden A., Gu A.Z. Mechanistic toxicity assessment of nanomaterials by whole-cell-array stress genes expression analysis. Environ Sci Technol 2010, 44(15):5964-5970.
48. Alpatova A.L., Shan W., Babica P., Upham B.L., Rogensues A.R., Masten S.J., et al. Single-walled carbon nanotubes dispersed in aqueous media via non-covalent functionalization: effect of dispersant on the stability, cytotoxicity, and epigenetic toxicity of nanotube suspensions. Water Res 2010, 44(2):505-520.
49. Ye S.F., Wu Y.H., Hou Z.Q., Zhang Q.Q. ROS and NF-[kappa]B are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. Biochem Biophy Res Commun 2009, 379(2):643-648.
50. Alon U., Surette M.G., Barkai N., Leibler S. Robustness in bacterial chemotaxis. Nature 1999, 397(6715):168-171.
51. Skerker J.M., Prasol M.S., Perchuk B.S., Biondi E.G., Laub M.T. Two-component signal transduction pathways regulating growth and cell cycle progression in a bacterium: a system-level analysis. PLoS Biol 2005, 3(10):334-353.
52. Chilcott G.S., Hughes K.T. Coupling of flagellar gene expression to flagellar assembly in Salmonella enterica Serovar Typhimurium and Escherichia coli. Microbiol Mol Biol Rev 2000, 64(4):694-708.
53. Muff T.J., Ordal G.W. The diverse CheC-type phosphatases: chemotaxis and beyond. Mol Microbiol 2008, 70(5):1054-1061.
54. Rosenthal K.S., Ferguson R.A., Storm D.R. Mechanism of action of EM 49, membrane-active peptide antibiotic. Antimicrob Agents Chemother 1977, 12(6):665-672.
55. Ortega Calvo J.J., Molina R., Jimenez Sanchez C., Dobson P.J., Thompson I.P. Bacterial tactic response to silver nanoparticles. Environ Microbiol Rep 2011, 3(5):526-534.
56. Ejim L., Farha M.A., Falconer S.B., Wildenhain J., Coombes B.K., Tyers M., et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol 2011, 7(6):348-350.